Allianz Asset Management
PRQR icon

Allianz Asset Management’s ProQR Therapeutics PRQR Stock Holding History

Allianz Asset Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-24,400
Closed -$134K – 2508
2020
Q1 		$134K Sell
24,400
-71,670
-75% -$550K ﹤0.01% 2372
2019
Q4 		$953K Buy
96,070
+64,945
+209% +$506K ﹤0.01% 2224
2019
Q3 		$181K Sell
31,125
-7,500
-19% -$59.9K ﹤0.01% 2645
2019
Q2 		$352K Sell
38,625
-3,520
-8% -$41.5K ﹤0.01% 2457
2019
Q1 		$584K Buy
42,145
+3,135
+8% +$46.8K ﹤0.01% 2271
2018
Q4 		$613K Buy
+39,010
New +$716K ﹤0.01% 2215

Other funds holding PRQR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Allianz Asset Management's PRQR Position: Q2 2020 in Review

Allianz Asset Management sold out of ProQR Therapeutics (PRQR) in Q2 2020, closing a stake of 24,400 shares — an estimated $134K sold.

Allianz Asset Management first reported a position in PRQR in Q4 2018 and held it in 6 quarters. The position peaked at $953K in Q4 2019. 44 funds tracked by Wall St. Rank hold PRQR as of Q2 2020.

  • Allianz Asset Management reported no remaining ProQR Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Allianz Asset Management sold 24,400 ProQR Therapeutics shares in Q2 2020, an estimated $134K.
  • Allianz Asset Management first reported a position in ProQR Therapeutics in Q4 2018 and held it in 6 quarters.
  • Allianz Asset Management's ProQR Therapeutics position peaked at $953K in Q4 2019.
  • 44 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.